GE HealthCare Technologies Inc.

NASDAQ:GEHC

Medical - Healthcare Information Services

Healthcare
$83.66 +0.74%

+$0.45 today

Market cap
$37.83B
Beta
0.86
P/E (TTM)
18.7
EPS (TTM)
$3.30
Dividend yield
0.23%
52W Low $58.75High $89.77

Volume 3.65M

Average 4.84M

GEHC Depreciation & Amortization

Non-cash expense that spreads the cost of physical and intangible assets over their useful lives.

GE HealthCare Technologies Inc.NASDAQ: GEHC

Depreciation & Amortization · Q2 FY2026 · quarter ended Jun 2026

Depreciation & amortization grows in line with its trailing trend

Q2 FY2026 depreciation & amortization of $160M rose 8.1% year over year, ahead of the +7.1% change in trailing-twelve-month depreciation & amortization. Sequentially, it rose 4.6% from the prior quarter. Over 3 fiscal years it compounded at -3.0% a year.

Context

  • Depreciation & amortization amounted to 2.8% of revenue in FY2025, down 0.1 pp from a year earlier.
  • Depreciation & amortization increased in 0 of the last 3 fiscal years.
  • FY2025 was the lowest annual figure in the 4 fiscal years shown.

What to watch

Whether quarterly growth of +8.1% holds above the trailing-twelve-month pace of +7.1%.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterJun 2026
$160M+4.6% QoQ
Last fiscal yearDec 2025
$578M-0.3% YoY
LTMJun 2026
$607M+7.1% YoY
Depreciation & Amortization past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+8.1%——
1 year-0.3%——
3-year CAGR-3.0%——
5-year CAGR——
10-year CAGR——

Depreciation & Amortization history

USD · from the income statement

Latest · FY2025
578M USD
Year-over-year change
-0.3%
4-year CAGR
-1.9%

Depreciation & Amortization vs competitors

How GEHC compares with its peers on the latest reported figures

  • Peers report in different currencies, so depreciation & amortization is compared through growth and share of revenue rather than absolute size.
  • Its year-over-year change of +7.1% is the 4th highest of 6, against a peer median of +7.5%.
  • Depreciation & amortization amounts to 3.0% of revenue for GEHC, versus a peer median of 6.7%.
GEHC Competitors
Depreciation & Amortization for GEHC and competitors
Company Period LTM YoY 3-year CAGR% of revenue
MDTMedtronic plcLTM Jul 2026$2.94B USD-0.3%+3.1%7.8%
ABTAbbott LaboratoriesLTM Sep 2026$2.54B USD-19.0%-1.6%5.3%
BSXBoston Scientific CorporationLTM Jun 2026$1.41B USD+7.5%+6.4%6.7%
SYKStryker CorporationLTM Jun 2026$1.25B USD+13.3%+6.1%4.8%
PHGKoninklijke Philips N.V.LTM Jun 2026€1.23B EUR+68.7%-11.1%7.0%
GEHCGE HealthCare Technologies Inc.LTM Jun 2026$607M USD+7.1%-3.0%3.0%
Peer median (excluding GEHC) —+7.5%+3.1%6.7%

Competitors are the stored peer set for GEHC. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue17.59B18.34B19.55B19.67B20.63B
Cost of Revenue10.41B11.16B11.63B11.47B12.38B
Gross Profit7.17B7.18B7.92B8.21B8.25B
Gross Margin40.8%39.1%40.5%41.7%40.0%
Research & Development816M1.03B1.21B1.31B1.26B
Selling, General & Admin3.56B3.63B4.28B4.27B4.23B
Operating Expenses4.38B4.66B5.49B5.58B5.49B
Depreciation & Amortization625M633M610M580M578M
EBITDA3.54B3.17B3.51B3.67B3.79B
EBITDA Margin20.1%17.3%18.0%18.6%18.4%
Operating Income2.8B2.52B2.44B2.63B2.76B
Operating Margin15.9%13.8%12.5%13.3%13.4%
Interest Income34M026M00
Interest Expense40M86M542M505M450M
Other Income / Expenses80M(10M)(74M)(44M)6M
Income Before Tax2.88B2.51B2.36B2.58B2.77B
Pre-Tax Margin16.3%13.7%12.1%13.1%13.4%
Income Tax Expense600M563M743M531M614M
Net Income2.25B1.92B1.57B1.99B2.08B
Net Margin12.8%10.4%8.0%10.1%10.1%
EPS (Basic)4.904.223.044.374.56
EPS (Diluted)4.904.223.024.344.55
Weighted Avg Shares454.71M453.93M455M456M456.52M
Weighted Avg Shares (Diluted)454.71M453.93M458M459M460.27M

GE HealthCare Technologies Inc.

NASDAQ:GEHC

Intrinsic Alpha fair value

Locked

Current Price

$83.66

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.